Table 1 Baseline characteristics of patients by miRNAs assessment set
From: The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer
| Characteristics | Screening set | Validation set | ||||
|---|---|---|---|---|---|---|
| Patient (n = 6) | Control (n = 6) | p | Patient (n = 88) | Control (n = 40) | p | |
| Average age | 64.7 ± 10.9 | 65.8 ± 7.1 | 0.930 | 65.1 ± 11.7 | 65.8 ± 12.2 | 0.821 |
| Gender | ||||||
| Male | 4 | 3 | 0.558 | 50 | 19 | 0.327 |
| Female | 2 | 3 | 38 | 21 | ||
| TNM staging | ||||||
| I | 7 | |||||
| II | 3 | 32 | ||||
| III | 3 | 49 | ||||
| pT category | ||||||
| pT 1 | 1 | |||||
| pT 2 | 8 | |||||
| pT 3 | 49 | |||||
| pT 4 | 6 | 30 | ||||
| Lymph nodes | ||||||
| Negative | 3 | 39 | ||||
| Positive | 3 | 49 | ||||
| Vascular invasion | ||||||
| Negative | 3 | 52 | ||||
| Positive | 3 | 36 | ||||
| Perineural invasion | ||||||
| Negative | 3 | 57 | ||||
| Positive | 3 | 31 | ||||
| Localization | ||||||
| Colon | 3 | 52 | ||||
| Rectum | 3 | 36 | ||||
| Grading | ||||||
| (adenocarcinoma) | ||||||
| Low | 1 | 14 | ||||
| Moderate | 4 | 63 | ||||
| High | 1 | 11 | ||||
| Tumor diameter | ||||||
| ≤5 cm | 2 | 39 | ||||
| >5 cm | 4 | 49 | ||||